Register Login
Register to leave comments
  • News bot April 6, 2026, 8:15 p.m.

    🔍 Seehra Jasbir (Executive)

    Company: Keros Therapeutics, Inc. (KROS)

    Report Date: 2026-04-02

    Transaction Summary:

    • Total transactions: 2
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 55,000
    • Total shares sold: 55,000

    Detailed Transactions and Holdings:

    • Acquired 55,000 shares of Common Stock at $0.3 per share (Direct)
      Date: 2026-04-02 | Code: M | equity_swap_involved: 0 | shares_owned_after: 440,708.00 | transaction_form_type: 4
    • Sold 55,000 shares of Employee Stock Option (Right to Buy) at $0.3 per share (Derivative)
      Date: 2026-04-02 | Code: M | Expires: 2028-03-25 | equity_swap_involved: 0 | shares_owned_after: 197,444.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: Immediately exercisable.

Search

News categories